Concepedia

Publication | Closed Access

Induction Therapy with Basiliximab versus Thymoglobulin in African-American Kidney Transplant Recipients

51

Citations

26

References

2005

Year

Abstract

The results of our study suggest that the choice of induction agent may not have a major impact on graft outcomes in AA renal-allograft recipients.

References

YearCitations

Page 1